We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$418M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$235M
3
EXEL icon
Exelixis
EXEL
+$219M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$191M
5
SJR
Shaw Communications Inc.
SJR
+$183M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$152M
2
CLVT icon
Clarivate
CLVT
+$127M
3
SGFY
Signify Health, Inc.
SGFY
+$113M
4
LHCG
LHC Group LLC
LHCG
+$111M
5
ATVI
Activision Blizzard
ATVI
+$87M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCFA
101
DELISTED
Perception Capital Corp. IV
RCFA
$6.28M 0.03%
600,000
– –
VYGR icon
102
Voyager Therapeutics
VYGR
$209M
$6.14M 0.03%
+797,000
New +$6.34M
SLAM
103
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$5.89M 0.03%
570,396
– –
VNET
104
VNET Group
VNET
$1.91B
$5.75M 0.03%
1,775,000
– –
BWC
105
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
$5.72M 0.03%
575,000
– –
ICE icon
106
Intercontinental Exchange
ICE
$90.5B
$5.41M 0.03%
+51,832
New +$5.4M
LBPH
107
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$5.29M 0.03%
1,560,500
+750,000
+93% +$3.66M
TIOA
108
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
$5.11M 0.03%
502,001
– –
GHIX
109
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
$5.04M 0.03%
500,000
– –
ATTO
110
DELISTED
Atento S.A.
ATTO
$4.64M 0.03%
2,230,357
– –
LGVC
111
DELISTED
LAMF Global Ventures Corp. I Class A Ordinary Shares
LGVC
$4.18M 0.02%
400,000
– –
FSRX
112
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$4.04M 0.02%
400,000
-200,000
-33% -$2.03M
FRXB
113
DELISTED
Forest Road Acquisition Corp. II
FRXB
$3.98M 0.02%
400,000
-850,000
-68% -$8.55M
CITE
114
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$3.69M 0.02%
350,000
– –
VMGA
115
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
$3.63M 0.02%
350,000
– –
UTAA
116
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
$3.58M 0.02%
344,100
– –
AMAM
117
DELISTED
Ambrx Biopharma Inc
AMAM
$3.22M 0.02%
+361,000
New +$1.81M
SPCM
118
DELISTED
Sound Point Acquisition Corp I, Ltd Class A Ordinary Share
SPCM
$3.17M 0.02%
300,000
– –
TECX
119
Tectonic Therapeutic
TECX
$736M
$3.12M 0.02%
259,667
+198,000
+321% +$2.76M
NUVB icon
120
Nuvation Bio
NUVB
$2.43B
$2.43M 0.01%
1,465,000
-652,600
-31% -$1.32M
PRVB
121
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2.17M 0.01%
+90,000
New +$1.13M
ARYD
122
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.06M 0.01%
200,000
-600,000
-75% -$6.12M
GATE
123
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.51M 0.01%
150,000
– –
ALNY icon
124
Alnylam Pharmaceuticals
ALNY
$31.6B
$1.35M 0.01%
6,719
-123,337
-95% -$25.9M
BPMC
125
DELISTED
Blueprint Medicines
BPMC
$1.01M 0.01%
22,420
-71,580
-76% -$3.22M
3 4
5
6 7

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2023 Portfolio in Review

As of Q1 2023, Thomas Steyer held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Thomas Steyer withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in UnitedHealth worth $409M.

  • Thomas Steyer's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Thomas Steyer added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Thomas Steyer's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Thomas Steyer fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Thomas Steyer's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Thomas Steyer opened 14 new positions and closed 63 in Q1 2023.
  • Thomas Steyer's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.